Skip to main content
Top
Published in: Thrombosis Journal 1/2018

Open Access 01-12-2018 | Case report

Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report

Authors: Elizabeth Sarah Mayne, Malcolm Tait, Barry Frank Jacobson, Evashin Pillay, Susan J. Louw

Published in: Thrombosis Journal | Issue 1/2018

Login to get access

Abstract

Background

Autoimmune paraphenomena, are associated with B-cell lymphoproliferative disorders, including monoclonal gammopathy of uncertain significance. These paraphenomena can rarely include acquired bleeding disorders.

Case presentation

This case study reports an unusual clinical presentation of 2 acquired bleeding disorders, Acquired von Willebrand syndrome (disease) and Acquired Glanzmann’s thrombasthenia, in an elderly patient with monoclonal gammopathy of uncertain significance.

Conclusions

Acquired bleeding disorders are often underdiagnosed and a high degree of clinical suspicion is required. The patient in this study demonstrated platelet aggregometry which was atypical for isolated Glanzmann’s thrombosthenia because of the severe concomitant endogenous decrease in von Willebrand factor. There was an absence of platelet aggregation to all tested agonists including ristocetin. Once the diagnosis was made, however, the patient showed a partial response to intravenous immunoglobulin confirming the immunological pathogenesis in this case. This case highlights the need to consider acquired bleeding disorders in patients with a possible predisposing factor.
Literature
1.
go back to reference Rajkumar SV, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–48.CrossRef Rajkumar SV, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–48.CrossRef
2.
go back to reference Shimanovsky A, et al. Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. BBA Clin. 2016;6:12–8.CrossRef Shimanovsky A, et al. Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. BBA Clin. 2016;6:12–8.CrossRef
3.
go back to reference James AH, Eikenboom J, Federici AB. State of the art: von Willebrand disease. Haemophilia. 2016;22(Suppl 5):54–9.CrossRef James AH, Eikenboom J, Federici AB. State of the art: von Willebrand disease. Haemophilia. 2016;22(Suppl 5):54–9.CrossRef
4.
go back to reference Federici AB, et al. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Semin Thromb Hemost. 2013;39(2):191–201.CrossRef Federici AB, et al. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Semin Thromb Hemost. 2013;39(2):191–201.CrossRef
5.
go back to reference Howard CR, et al. IgG kappa monoclonal gammopathy of undetermined significance presenting as acquired type III Von Willebrand syndrome. Blood Coagul Fibrinolysis. 2014;25(6):631–3.CrossRef Howard CR, et al. IgG kappa monoclonal gammopathy of undetermined significance presenting as acquired type III Von Willebrand syndrome. Blood Coagul Fibrinolysis. 2014;25(6):631–3.CrossRef
6.
go back to reference Solh T, Botsford A, Solh M. Glanzmann’s thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options. J Blood Med. 2015;6:219–27.CrossRef Solh T, Botsford A, Solh M. Glanzmann’s thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options. J Blood Med. 2015;6:219–27.CrossRef
7.
go back to reference Michiels JJ, et al. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol. 2001;14(2):401–36.CrossRef Michiels JJ, et al. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Haematol. 2001;14(2):401–36.CrossRef
8.
go back to reference Federici AB. Diagnosis of inherited von Willebrand disease: a clinical perspective. Semin Thromb Hemost. 2006;32(6):555–65.CrossRef Federici AB. Diagnosis of inherited von Willebrand disease: a clinical perspective. Semin Thromb Hemost. 2006;32(6):555–65.CrossRef
9.
go back to reference De Jong A, Eikenboom J. Developments in the diagnostic procedures for von Willebrand disease. J Thromb Haemost. 2016;14(3):449–60.CrossRef De Jong A, Eikenboom J. Developments in the diagnostic procedures for von Willebrand disease. J Thromb Haemost. 2016;14(3):449–60.CrossRef
10.
go back to reference Budde U, Bergmann F, Michiels JJ. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry. Semin Thromb Hemost. 2002;28(2):227–38.CrossRef Budde U, Bergmann F, Michiels JJ. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry. Semin Thromb Hemost. 2002;28(2):227–38.CrossRef
11.
go back to reference Siaka C, et al. A new ELISA assay for diagnosis of acquired von Willebrand syndrome. Haemophilia. 2003;9(3):303–8.CrossRef Siaka C, et al. A new ELISA assay for diagnosis of acquired von Willebrand syndrome. Haemophilia. 2003;9(3):303–8.CrossRef
12.
go back to reference Federici AB. Acquired von Willebrand syndrome: is it an extremely rare disorder or do we see only the tip of the iceberg? J Thromb Haemost. 2008;6(4):565–8.CrossRef Federici AB. Acquired von Willebrand syndrome: is it an extremely rare disorder or do we see only the tip of the iceberg? J Thromb Haemost. 2008;6(4):565–8.CrossRef
13.
go back to reference Solh M, et al. Acquired Glanzmann’s thrombasthenia with optimal response to rituximab therapy. Am J Hematol. 2011;86(8):715–6.CrossRef Solh M, et al. Acquired Glanzmann’s thrombasthenia with optimal response to rituximab therapy. Am J Hematol. 2011;86(8):715–6.CrossRef
14.
go back to reference Tholouli E, et al. Acquired Glanzmann’s thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder. Br J Haematol. 2004;127(2):209–13.CrossRef Tholouli E, et al. Acquired Glanzmann’s thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder. Br J Haematol. 2004;127(2):209–13.CrossRef
Metadata
Title
Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report
Authors
Elizabeth Sarah Mayne
Malcolm Tait
Barry Frank Jacobson
Evashin Pillay
Susan J. Louw
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Thrombosis Journal / Issue 1/2018
Electronic ISSN: 1477-9560
DOI
https://doi.org/10.1186/s12959-018-0184-2

Other articles of this Issue 1/2018

Thrombosis Journal 1/2018 Go to the issue